New device can detect oral cancer

September 2007
Hudson Valley Business Journal;9/3/2007, Vol. 18 Issue 36, p17
Product Review
The article evaluates the VELscope® System hand-held device to detect oral cancer from the British Columbia Cancer Agency and LED Dental Inc.


Related Articles

  • LED Dental, Schein ink exclusive pact.  // Proofs;Mar2011, Vol. 94 Issue 2, p26 

    The article reports on the selection of Henry Schein Dental as the exclusive distributor of LED Dental's VELscope Vx Enhanced Oral Assessment system in North America.

  • An endoscopic fluorescence imaging system for simultaneous visual examination and photodetection of cancers. Wagnieres, Georges A.; Studzinski, Andre P.; van den Bergh, Hubert E. // Review of Scientific Instruments;Jan1997, Vol. 68 Issue 1, p203 

    Describes the design and performance tested during six years of clinical trials of a fluorescence endoscope for the detection and delineation of cancers in several hollow organs. Operating principle of the photodetection apparatus; Characteristics of the apparatus; Illustration of the results...

  • VELscope Vx receives CE Mark.  // Proofs;Nov2011, Vol. 94 Issue 5, p35 

    The article reports on the European Conformity (CE) Mark approval obtained by the VELscope Vx oral health screening device from LED Dental Inc., which manifests that the VELscope Vx has met the health and safety standards of the European Union (EU).

  • VELscope distribution expanded.  // Proofs;Nov2008, Vol. 91 Issue 5, p97 

    The article reports that the VELscope Oral Cancer Screening System from LED Dental Inc. has official distribution agreements in 25 countries. This system is being distributed in the U.S. which is its largest market and Canada. The other countries and their respective VELscope system distributors...

  • Cancer Fighter. Gawel, Richard; Konish, Nancy // Electronic Design;06/14/99, Vol. 47 Issue 12, p64B 

    Introduces T-Scan 2000 device used in tumor detection on women breast developed by TransScan Medical Inc. in Ramsey, New Jersey. Description of the T-Scan 200 device; Efficacy and limitations of the device; Condition for the approval of the device; Contact information.

  • SENORX GETS 510(K) CLEARANCE FOR SINGLE STEP BIOPSY DEVICE.  // Biotech Equipment Update;Oct2002, p1 

    Reports that medical device company SenoRx Inc. has received 510 (k) clearance from U.S. Food and Drug Administration to market its Single Step breast biopsy device for the diagnosis of breast cancer. Uses of the device; Investors in the company; Other devices for which the company has received...

  • EXACT SCIENCES REPORTS NET LOSS OF 7.6 MILLION FOR FIRST QTR.  // Biotech Financial Reports;Jun2002, p6 

    Reports on financial results of cancer diagnostic equipment company Exact Sciences Corp. for the first quarter of 2002. Net loss reported by the company for the quarter; Factors which resulted in losses for the company; Recognition given to scientists and clinicians of the company by various...

  • Cancer Catchers. Deans, Alan // Bulletin with Newsweek;10/16/2001, Vol. 119 Issue 6297, p12 

    Details the development of Truscan, a cancer detection device. Conduction of independent trials in six countries to win approval from European regulators; Description of Truscan; Number of individual tests for the accuracy of Truscan. INSET: Healthy profits, by Alan Deans..

  • Testing of BCC detection device begins in Canada. Guttman, Cheryl // Dermatology Times;Feb2000, Vol. 21 Issue 2, p8 

    Evaluates the SCD-1 Skin Cancer Detection System from Biomax Technologies Inc. in Canada. Use of the device in delineating and defining basal cell carcinoma borders; Differentiation between normal skin and basal cell carcinoma; Analysis of tumor borders with natural room light; Removal of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics